Therapeutic options in VEXAS syndrome: insights from a retrospective series

Blood. 2021 Jul 1;137(26):3682-3684. doi: 10.1182/blood.2020010177.
No abstract available

Publication types

  • Review

MeSH terms

  • Genetic Diseases, Inborn* / enzymology
  • Genetic Diseases, Inborn* / genetics
  • Humans
  • Mutation*
  • Mutation, Missense*
  • Myeloproliferative Disorders* / enzymology
  • Myeloproliferative Disorders* / genetics
  • Syndrome
  • Ubiquitin-Activating Enzymes / genetics*

Substances

  • UBA1 protein, human
  • Ubiquitin-Activating Enzymes